List view / Grid view
5 May 2015 | By Victoria White
MJFF and Prothena have teamed up to accelerate the discovery of novel biomarkers and development of assays to measure Parkinson's disease progression...
5 May 2015 | By Victoria White
ReNeuron has received approval from the FDA to commence a Phase I/II clinical trial in the US with its hRPC therapy candidate for retinitis pigmentosa...
30 April 2015 | By Victoria White
Researchers have found that ITIM - receptors are important to the development of acute myeloid leukaemia (AML), providing a target for potential therapies...
30 April 2015 | By Victoria White
Scientists at Helmholtz Zentrum München have succeeded in testing the effectiveness of new approaches for treating COPD on ex vivo 3D-LTCs...
30 April 2015 | By Victoria White
NIH funded project to identify the causes of schizophrenia and other neurodevelopmental disorders to guide development of more effective treatments...
30 April 2015 | By Victoria White
Biotech companies presented new mechanisms and approaches in the global fight against infections in a pipeline session at ECCMID...
29 April 2015 | By Victoria White
An international team of scientists has identified a new genetic mutation that appears to protect people from developing Type 2 diabetes...
29 April 2015 | By Victoria White
Inhibiting HDACs has shown significant potential in stimulating the growth of brain cells and memory restoration in animal models that mimic Alzheimer’s...
28 April 2015 | By Victoria White
A new function now described for the protein dDsk2 links ubiquitin receptors for the first time with the regulation of gene expression...
28 April 2015 | By Victoria White
Researchers at the Institut Hospital del Mar d’Investigacions Mèdiques (IMIM) have identified a new way of treating colorectal cancer...
28 April 2015 | By Victoria White
A team at CSHL has published results of experiments that lay bare a previously unknown pathway activated in HER2-positive breast cancer...
27 April 2015 | By Victoria White
4DMT and Roche are to collaborate to discover and develop optimised next-generation AAV vectors for indications with high unmet medical need...
27 April 2015 | By Victoria White
Stealth BioTherapeutics has expanded its ophthalmology programme, led by Ocuvia, with FDA granting a Type B meeting for inherited optic neuropathies...
27 April 2015 | By Victoria White
NanoViricides has discussed the significance of the effectiveness demonstrated by its anti-viral drug candidates in a lethal animal model of dermal herpes...
27 April 2015 | By Victoria White
Preclinical data from Synthetic Biologics’ novel SYN-005 programme for the treatment of Pertussis were presented in two posters at ECCMID 2015...
